Novartis Takes Fight To The FDA After US Entresto Generic Approval

 
• By Dean Rudge

Novartis continues to fight tooth and nail to protect its $3bn Entresto brand in the US following the latest FDA approval of a generic version.

Lawsuits magnifying glass
Novartis wants a court to set aside the FDA's approval of an Entresto generic. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics